The relationship between the two was first discovered by Rottenberg et al. The group’s experiments demonstrated that in a breast tumor model, the emergence of PARPi-acquired resistance is related to upregulation of P-gp expression, and that the P-gp inhibitor tariquidar can reverse its overexpression (Rottenberg et al., 2008). The gene discussed is PGP; the disease is breast neoplasm.